Gaipa, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 5.095
EU - Europa 2.101
AS - Asia 850
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 6
AF - Africa 5
SA - Sud America 5
Totale 8.073
Nazione #
US - Stati Uniti d'America 5.020
IT - Italia 424
CN - Cina 389
SE - Svezia 382
DE - Germania 331
IE - Irlanda 305
SG - Singapore 191
UA - Ucraina 157
RU - Federazione Russa 155
GB - Regno Unito 117
HK - Hong Kong 95
CA - Canada 74
VN - Vietnam 57
FI - Finlandia 54
BE - Belgio 46
IN - India 45
TR - Turchia 38
DK - Danimarca 37
FR - Francia 33
ID - Indonesia 19
AT - Austria 13
EU - Europa 11
NL - Olanda 10
RO - Romania 8
ES - Italia 6
IR - Iran 6
AU - Australia 5
CZ - Repubblica Ceca 5
KR - Corea 4
BG - Bulgaria 3
PK - Pakistan 3
RS - Serbia 3
AR - Argentina 2
GR - Grecia 2
JP - Giappone 2
LU - Lussemburgo 2
MU - Mauritius 2
NG - Nigeria 2
NO - Norvegia 2
SI - Slovenia 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BR - Brasile 1
CH - Svizzera 1
CO - Colombia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PL - Polonia 1
PR - Porto Rico 1
SC - Seychelles 1
Totale 8.073
Città #
Ann Arbor 1.404
Woodbridge 454
Chandler 390
Fairfield 378
Wilmington 354
Dublin 296
Houston 289
Frankfurt am Main 227
Ashburn 209
Jacksonville 180
Dearborn 157
Seattle 145
Singapore 137
Milan 128
New York 123
Cambridge 122
Princeton 99
Hong Kong 92
Shanghai 75
Nanjing 65
Altamura 53
Lawrence 47
Lissone 44
Brussels 42
Beijing 36
Fremont 35
San Diego 33
Lachine 30
Dong Ket 29
Hangzhou 26
Santa Clara 26
Boardman 24
Helsinki 22
Nanchang 22
Guangzhou 20
Jakarta 19
Kocaeli 18
Jinan 17
Andover 16
Hebei 16
Tianjin 16
Toronto 16
Shenyang 15
Los Angeles 12
Ottawa 12
Vienna 12
Edmonton 11
Kunming 11
Ningbo 11
Pune 11
Mountain View 10
Zhengzhou 10
Jiaxing 9
Munich 9
Redmond 9
Monza 8
Göttingen 7
London 7
Norwalk 7
Taizhou 7
Turin 7
Besana In Brianza 6
Chicago 6
Falls Church 6
Huizen 6
Auburn Hills 5
Changsha 5
Kiev 5
Moscow 5
Rome 5
San Mateo 5
Brookline 4
Dallas 4
Desio 4
Hefei 4
Madrid 4
Mumbai 4
Nürnberg 4
Sacramento 4
West Jordan 4
Brno 3
Brugherio 3
Carate Brianza 3
Faisalabad 3
Gap 3
Grafing 3
Lecco 3
Napoli 3
Rho 3
Serina 3
Somma Lombardo 3
University Park 3
Washington 3
Wuhan 3
Acquafredda 2
Annone di Brianza 2
Ardabil 2
Bath 2
Bollate 2
Brescia 2
Totale 6.260
Nome #
Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric Patients 314
Metronomic combination of Vinorelbine and 5Fluorouracil is able to inhibit triple-negative breast cancer cells. Results from the proof-of-concept VICTOR-0 study. 292
Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation 286
Simultaneous overexpression of human E5NT and ENTPD1 protects porcine endothelial cells against H2O2-induced oxidative stress and cytotoxicity in vitro 281
Development of advanced therapies in Italy: Management models and sustainability in six Italian cell factories 273
Simultaneous overexpression of functional human HO-1, E5NT and ENTPD1 protects murine fibroblasts against TNF-α-induced injury in vitro 267
Mesenchymal stromal cells for the treatment of graft-versus-host disease: understanding the in vivo biological effect through patient immune monitoring 257
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Human Mesenchymal Stromal Cells: A Phase 1 Study On 47 Adult and Pediatric Patients 251
Full GMP-Compliant Validation of Bone Marrow-Derived Human CD133+ Cells as Advanced Therapy Medicinal Product for Refractory Ischemic Cardiomyopathy 237
Regulatory T cells and extracorporeal photochemotherapy: correlation with clinical response and decreased frequency of proinflammatory T cells. 231
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 229
The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL 223
GMP-grade preparation of biomimetic scaffolds with osteo-differentiated autologous mesenchymal stromal cells for the treatment of alveolar bone resorption in periodontal disease 213
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia 210
Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population 197
Evidence of ETNK1 Somatic Variants in Atypical Chronic Myeloid Leukemia 196
Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: A phase I study 192
Mesenchymal stromal cells do not increase the risk of viral reactivation nor the severity of viral events in recipients of allogeneic stem cell transplantation 192
Transposon-Based CAR T Cells in Acute Leukemias: Where are We Going? 192
Absent B cells, agammaglobulinemia, and hypertrophic cardiomyopathy in folliculin-interacting protein 1 deficiency 192
Defining the correct role of minimal residual disease tests in the management of acute lymphoblastic leukaemia 169
The TGF-β pathway is activated by 5-fluorouracil treatment in drug resistant colorectal carcinoma cells 164
Characterization of migratory activity and cytokine profile of helper and cytotoxic CMV-specific T-cell lines expanded by a selective peptide library 160
Intravenous infusion of human bone marrow mesenchymal stromal cells promotes functional recovery and neuroplasticity after ischemic stroke in mice 158
Flow cytometry for minimal residual disease testing in acute leukemia: opportunities and challenges 158
Allogeneic mesenchymal stem cell infusion for the stabilization of focal segmental glomerulosclerosis 157
Fine Tuning of Surface CRLF2 Expression and Its Associated Signalling Profile in Childhood B Cell Precursor Acute Lymphoblastic Leukemia 151
Isolation of monocytes from leukapheretic products for large-scale GMP-grade generation of cytomegalovirus-specific T-cell lines by means of an automated elutriation device 150
Failure of interferon-γ pre-treated mesenchymal stem cell treatment in a patient with crohn's disease 146
Single-cell developmental classification of B cell precursor acute lymphoblastic leukemia at diagnosis reveals predictors of relapse 146
Single-cell profiling of pediatric T-cell acute lymphoblastic leukemia: Impact of PTEN exon 7 mutation on PI3K/Akt and JAK–STAT signaling pathways 146
Simultaneous over-expression of graft protective hHO-1, hCD73 and hCD39: effects against cell cytotoxicity and cell death induced by the inflammatory cytokine TNF-α in an in vitro model 145
CRLF2 over-expression is a poor prognostic marker in children with high risk T-cell acute lymphoblastic leukemia 142
Noonan Syndrome Peripheral Blood Cells Show Enhanced Spontaneous Colonies Growth In Vitro and Hyperactive JAK and RAS Intracellular Signalling Pathways 137
Differential expression of CD73, CD86 and CD304 in normal vs. leukemic B-cell precursors and their utility as stable minimal residual disease markers in childhood B-cell precursor acute lymphoblastic leukemia 137
SRC/ABL inhibition disrupts CRLF2-driven signaling to induce cell death in B-cell acute lymphoblastic leukemia 136
PAX5 Fusion Genes Activate The STAT5 Signaling Pathway Through Lck Over-Expression 135
Efficient lentiviral transduction of primary human acute myelogenous and lymphoblastic leukemia cells 134
Redirecting T cells with Chimeric Antigen Receptor (CAR) for the treatment of childhood acute lymphoblastic leukemia 128
Fine tuning of surface CRLF2 expression and its associated signaling profile in childhood B-cell precursor acute lymphoblastic leukemia 124
Peripheral blood cells from children with RASopathies show enhanced spontaneous colonies growth in vitro and hyperactive RAS signaling 114
CD40 ligand-stimulated B cell precursor leukemic cells elicit interferon-gamma production by autologous bone marrow T cells in childhood acute lymphoblastic leukemia 113
LONG TERM SURVIVAL AND EFFICACY OF HUMAN BONE MARROW MESENCHYMAL STEM CELLS IN TRAUMATIZED MICE BRAIN IS NOT DEPENDENT ON IMMUNOSUPPRESSIVE TREATMENT. 102
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia 99
Simultaneous expression of novel combinations of graft protective human genes in porcine endothelial cells 96
Monitoring of minimal residual disease in leukemia, advantages and pitfalls 84
A comprehensive report of long-term stability data for a range ATMPs: A need to develop guidelines for safe and harmonized stability studies 60
Linking cell function with perfusion: Insights from the transcatheter delivery of bone marrow-derived CD133 + cells in ischemic refractory cardiomyopathy trial (RECARDIO) 11 Medical and Health Sciences 1103 Clinical Sciences 11 Medical and Health Sciences 1102 Cardiorespiratory Medicine and Haematology 53
Flow cytometric minimal residual disease assessment in B-cell precursor acute lymphoblastic leukaemia patients treated with CD19-targeted therapies — a EuroFlow study 53
Deep immunophenotypic characterization of CARCIK-CD19 pre-infusion cellular product by advanced multiparametric flow cytometry 33
Long-Term Host Immune Modulation Following Tisagenlecleucel Administration in Patients with Diffuse Large B-Cell Lymphoma and B-Lineage Acute Lymphoblastic Leukemia 30
Bone Marrow Stromal Cell Regeneration Profile in Treated B-Cell Precursor Acute Lymphoblastic Leukemia Patients: Association with MRD Status and Patient Outcome 28
Minimal residual disease assessment in B-cell precursor acute lymphoblastic leukemia by semi-automated identification of normal hematopoietic cells: A EuroFlow study 19
Totale 8.532
Categoria #
all - tutte 26.445
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.445


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.251 0 0 100 118 130 180 217 95 146 108 116 41
2020/20211.634 47 112 206 176 137 139 149 107 135 177 93 156
2021/2022986 99 116 114 75 56 75 41 49 91 85 69 116
2022/20231.460 153 476 107 144 71 209 37 85 100 9 43 26
2023/2024962 29 29 48 54 134 246 185 32 53 26 18 108
2024/2025315 102 192 21 0 0 0 0 0 0 0 0 0
Totale 8.532